ELZA and the Second Global Consensus on Keratoconus and Ectatic Diseases
The Second Global Consensus on Keratoconus and Ectatic Diseases was published today, and ELZA played a key role in its development.
Mark Hillen
June 2, 2026
The Second Global Consensus on Keratoconus and Ectatic Diseases was published today, and ELZA played a key role in its development.
Nikki and Farhad Hafezi are representing ELZA in China this week with invited presentations on corneal cross-linking, keratoconus, refractive surgery safety, PACK-CXL, and K-MAP.
Prof. Farhad Hafezi discusses ECO-CAIRS, a strategy using high-fluence CXL to optimise allogenic ring segments for keratoconus.
ELZA-affiliated researchers publish a JCRS study on ultra-high-fluence cross-linking for allogenic corneal ring segments.
As the Eye Clinic KBC Zvezdara celebrates 60 years, current debates in ophthalmology focus on the shift from standardized protocols to personalized treatment for keratoconus and corneal ectasia.
Insights from ELZA’s contributions to the World Keratoconus Congress 2026 in Florence – ELZA PACE, CXL innovation, and personalised keratoconus treatment strategies
At the 10th SAoO Congress in Lucerne, Dr. Emilio Torres-Netto examined how advances in keratoconus care may further reduce the need for keratoplasty by 2040
ELZA’s CEO and CMO, Nikki and Farhad Hafezi flew to Hong Kong to attend APAO 2026, including an invited symposium presentation by Prof. Farhad Hafezi on Custom CXL.
A January 2026 The Ophthalmologist article outlines how personalised CXL is applied in three real-world scenarios: good vision, cataract planning, and markedly irregular corneas.
At Swiss Eye Week 2026 in Thun, Prof Farhad Hafezi contributed to ophthalmology education with lectures on corneal cross-linking and ectasia rehabilitation.
